Moleculin Biotech, Inc. · NASDAQ:MBRX

Klemp Walter V exercised options for 577 Moleculin Biotech, Inc. shares (Form 4)

Traded Nov 16, 2026 · Filed Nov 18, 2026

On Nov 16, 2026, Klemp Walter V (Director, CEO and President) exercised options for 577 Moleculin Biotech, Inc. shares, leaving 36,545 shares. Filed Nov 18, 2026 (Form 4).

Options exercised
577 shares
Holding after
36,545 shares
Trading plan
No
Role
Director, CEO and President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common StockOption exercise57736,686Direct
Nov 16, 2026Common StockShares withheld for tax141US$7.4136,545Direct

Source

Download original · View original at SEC

Related